PerkinElmer Completes Acquisition of Latent TB Diagnostics Specialist
Oxford Immunotec is recognized as a global leader of proprietary test kits for latent tuberculosis. known for its T-SPOT.TB test.
Read MorePosted by Melanie Hamilton-Basich | Mar 19, 2021 | Tuberculosis |
Oxford Immunotec is recognized as a global leader of proprietary test kits for latent tuberculosis. known for its T-SPOT.TB test.
Read MorePosted by Laurie Bonner | Mar 19, 2021 | Swabs |
In lab tests, the porous nanofiber cylinders absorbed and released more proteins, cells, bacteria, DNA, and viruses from liquids and surfaces than the cotton or flocked swabs commonly used for covid-19 testing.
Read MorePosted by Laurie Bonner | Mar 19, 2021 | Covid 19, Molecular Diagnostics |
The new panel includes SARS-CoV-2 among 19 viral and two bacterial common respiratory pathogens.
Read MorePosted by Laurie Bonner | Mar 18, 2021 | Covid 19, Molecular Diagnostics |
The BioFire Respiratory Panel 2.1 is the first SARS-CoV-2 diagnostic that will be permitted to be marketed beyond the public health emergency.
Read MorePosted by Melanie Hamilton-Basich | Mar 17, 2021 | Company News |
“Acquiring GenMark Diagnostics will broaden our molecular diagnostics portfolio to include solutions that can provide lifesaving information quickly to patients and their healthcare providers in the fight against infectious diseases,” says Thomas Schinecker, CEO Roche Diagnostics.
Read More